Relafen 750, a unique preparation of naproxen, presents a compelling example from our biochemical pharmacy perspective. Its process of action, primarily involving blocking of cyclooxygenase enzymes and COX-1 and COX-2 – leads to the decrease in prostaglandin creation. Considering the biochemical framework, the drug's potency is closely related to